Plasmon-enhanced circular dichroism spectroscopy of chiral drug solutions

TL;DR

This paper explores how surface plasmon polaritons can significantly enhance circular dichroism signals for detecting small amounts of chiral drug solutions, enabling sensitive chiroptical sensing.

Contribution

It demonstrates the use of noble metal surface plasmon polaritons in Otto and Kretschmann configurations to enhance chiroptical signals from dilute drug solutions, a novel approach for sensitive detection.

Findings

Achieved a circular-dichroism differential absorption enhancement factor of about 20.

Showed sensitivity to small drug volumes (~100 nm) near the metal surface.

Observed chirality-induced polarization distortion in plasmonic excitation.

Abstract

We investigate the potential of surface plasmon polaritons at noble metal interfaces for surface-enhanced chiroptical sensing of dilute chiral drug solutions. The high quality factor of surface plasmon resonances in both Otto and Kretschmann configurations enables the enhancement of circular dichroism differenatial absorption thanks to the large near-field intensity of such plasmonic excitations. Furthermore, the subwavelength confinement of surface plasmon polaritons is key to attain chiroptical sensitivity to small amounts of drug volumes placed around $\simeq 100$ nm by the metal surface. Our calculations focus on reparixin, a pharmaceutical molecule currently used in clinical studies for patients with community-acquired pneumonia, including COVID-19 and acute respiratory distress syndrome. Considering realistic dilute solutions of reparixin dissolved in water with concentration $\leq 5$ mg$/$ml, we find a circular-dichroism differential absorption enhancement factor of the order $\simeq 20$ and chirality-induced polarization distortion upon surface plasmon polariton excitation.